Cibc World Markets Corp Acadia Pharmaceuticals Inc Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Cibc World Markets Corp holds 15,335 shares of ACAD stock, worth $343,043. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,335
Previous 26,554
42.25%
Holding current value
$343,043
Previous $441,000
25.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACAD
# of Institutions
353Shares Held
164MCall Options Held
811KPut Options Held
334K-
Baker Bros. Advisors LP New York, NY42.9MShares$960 Million9.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.3MShares$341 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$270 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY9MShares$201 Million2.98% of portfolio
-
State Street Corp Boston, MA6.18MShares$138 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.62B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...